Cookies on oxfam

We use cookies to ensure that you have the best experience on our website. If you continue browsing, we’ll assume that you are happy to receive all our cookies. You can change your cookie settings at any time. Find out more Close

  • Grows vegetables
  • Fills classrooms
  • Drills wells
  • Empowers women
  • Fights poverty

Integrated Cardiac Safety

£24.99

Product description

Integrated Cardiac Safety - Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance

The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students. A new, more effective approach for screening drugs for adverse cardiac effects In recent years, more drugs have been withdrawn from the market for cardiac safety than for any other reason, underscoring the need for better methods and strategies to screen drugs for adverse cardiac effects. Integrated cardiac safety, this book's central tenet, sets forth an effective strategy that enables researchers in drug discovery and development to better assess the cardiac safety of drugs. It entails the use and integration of the methodologies used to assess cardiac safety during the full life cycle of drug development from discovery and design through to postmarketing surveillance. Moreover, the integrated cardiac safety approach demonstrates the benefit of integrating proarrhythmic, generalized, and behavioral cardiac safety issues rather than treating them separately.

This book deals with drugs that are not indicated for cardiac diseases or conditions. It begins with an introduction to cardiac safety assessment and the biology of adverse drug interactions. Following sections on cardiac function and cardiac pathophysiology and disease, the authors guide readers through the assessment process during discovery, preapproval (including QT/QTc trials), and postmarketing surveillance. The book concludes with chapters on medication errors and an examination of future trends in drug safety.

"Turner and Durham's book is well organized and comprehensive, providing both historical and prospective viewpoints. It provides practical information on drug safety throughout life cycle development, from molecular biology to postmarketing surveillance. It will be an invaluable source of information for those who want to learn about this area, as well as for basic scientists, clinical investigators, physicians, and regulators currently wrestling with the diverse challenges of cardiac safety." Peter K. S. Siegl, PhD, Siegl Pharma Consulting LLC

"At a moment in health care history when public policy and the practice of medicine are on a collision course and meta-analysis madness threatens to derail twenty-first-century drug development, Turner and Durham strive to return us to the right path, the Critical Path, brightly lit by practical advice and sound science. This is a timely and important book." Peter J. Pitts, PhD, President, Center for Medicine in the Public Interest, and former Associate Commissioner, FDA
"Professors Turner and Durham provide a forward-looking guide to medication safety issues relevant to all classes of pharmaceuticals. And their guidance could not be more timely. The public and policymakers are increasingly and rightly focused on safety issues at both the development and postmarketing stages. The authors provide a synthesis of medication safety issues that is comprehensive, accessible, and that speaks to a wide range of health care professionals. Integrated Cardiac Safety is an important, and welcome, work." Jay Campbell, JD, RPh, Executive Director, North Carolina Board of Pharmacy

Item details

Author(s):
Turner, J. Rick; Durham, Todd A.
Condition:
Fine
Edition:
2009
Format:
Hardback
ISBN-10:
0470229640
ISBN-13:
9780470229644
Number of pages:
470
Publisher:
Wiley

Standard UK Delivery (£3.95 per order)

Delivery FAQs

Free returns

within 21 days.
Returns policy

About this item

Integrated Cardiac Safety - Assessment Methodologies for Noncardiac Drugs in Discovery, Development, and Postmarketing Surveillance

The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, government officials, and students. A new, more effective approach for screening drugs for adverse cardiac effects In recent years, more drugs have been withdrawn from the market for cardiac safety than for any other reason, underscoring the need for better methods and strategies to screen drugs for adverse cardiac effects. Integrated cardiac safety, this book's central tenet, sets forth an effective strategy that enables researchers in drug discovery and development to better assess the cardiac safety of drugs. It entails the use and integration of the methodologies used to assess cardiac safety during the full life cycle of drug development from discovery and design through to postmarketing surveillance. Moreover, the integrated cardiac safety approach demonstrates the benefit of integrating proarrhythmic, generalized, and behavioral cardiac safety issues rather than treating them separately.

This book deals with drugs that are not indicated for cardiac diseases or conditions. It begins with an introduction to cardiac safety assessment and the biology of adverse drug interactions. Following sections on cardiac function and cardiac pathophysiology and disease, the authors guide readers through the assessment process during discovery, preapproval (including QT/QTc trials), and postmarketing surveillance. The book concludes with chapters on medication errors and an examination of future trends in drug safety.

"Turner and Durham's book is well organized and comprehensive, providing both historical and prospective viewpoints. It provides practical information on drug safety throughout life cycle development, from molecular biology to postmarketing surveillance. It will be an invaluable source of information for those who want to learn about this area, as well as for basic scientists, clinical investigators, physicians, and regulators currently wrestling with the diverse challenges of cardiac safety." Peter K. S. Siegl, PhD, Siegl Pharma Consulting LLC

"At a moment in health care history when public policy and the practice of medicine are on a collision course and meta-analysis madness threatens to derail twenty-first-century drug development, Turner and Durham strive to return us to the right path, the Critical Path, brightly lit by practical advice and sound science. This is a timely and important book." Peter J. Pitts, PhD, President, Center for Medicine in the Public Interest, and former Associate Commissioner, FDA
"Professors Turner and Durham provide a forward-looking guide to medication safety issues relevant to all classes of pharmaceuticals. And their guidance could not be more timely. The public and policymakers are increasingly and rightly focused on safety issues at both the development and postmarketing stages. The authors provide a synthesis of medication safety issues that is comprehensive, accessible, and that speaks to a wide range of health care professionals. Integrated Cardiac Safety is an important, and welcome, work." Jay Campbell, JD, RPh, Executive Director, North Carolina Board of Pharmacy

Author(s):
Turner, J. Rick; Durham, Todd A.
Condition:
Fine
Edition:
2009
Format:
Hardback
ISBN-10:
0470229640
ISBN-13:
9780470229644
Number of pages:
470
Publisher:
Wiley

Delivery & returns

This item will be dispatched to UK addresses via second class post within 2 working days of receipt of your order. Standard UK delivery is £3.95 per order, so you're only charged once no matter how many items you have in your basket. Any additional courier charges will be applied at checkout as they vary depending on delivery address.

This item will be dispatched to UK addresses via second class post within 2 working days of receipt of your order. Standard UK delivery is currently free, no matter how many items you have in your basket. Any additional courier charges will be applied at checkout as they vary depending on delivery address.

You can find out more about delivery and returns in our help section.

We offer a no quibble returns policy as follows:

Wedding dresses: 14 days

Overseas returns: 31 days

Everything else: 21 days


This item is also available for international delivery by airmail, carrying a mandatory delivery charge of:

Europe: £8.00

Outside Europe: £15.00

Volunteer listed

Wonder how this unique item ended up online?

Most of the second-hand items you see online have been donated, by supporters like you, to our high street stores. Each item is then priced, photographed and listed on this site by our amazing team of volunteers from across the country.

After you have bought your item, our team of volunteers package and dispatch it from the Shop straight to you or your chosen recipient.

All profits from the sales of our goods go towards funding Oxfam's work around the world. We rely on your donations to sell online so please keep the cycle of goodness going!

To find out more about volunteering with Oxfam, please visit our how to volunteer page.

Oxfam Bookshop Raeburn Place

The Oxfam Book Shop in Stockbridge, Edinburgh has long been a city favourite, with an excellent range of quality second hand titles and also a team of enthusiasts who love and understand books. Please don't hesitate to contact us on 0131 332 9632 or oxfamf5817@oxfam.org.uk and let us help you find that elusive book.

View Shop